序贯多分配随机试验的成本效果分析
序贯多分配随机试验(SMART)日益流行,其方案常提出对嵌入式自适应策略进行成本效果分析,通常采用增量成本效果比(ICER)评估。本文提出SMART设计中嵌入式动态治疗方案的ICER估计与推断方法,具体描述基于影响曲线推断的靶向最大似然估计,并通过模拟展示方法性能。全文以ADAPT-R试验(NCT02338739)为例,给出旨在提高HIV护理依从性的嵌入式方案的ICER估计及推断。本文是最早呈现SMART成本效果分析结果的手稿之一。
要点
- SMART中嵌入式动态治疗方案的ICER可用靶向最大似然估计进行估计与推断。
- 方法通过模拟评估性能,并以ADAPT-R试验为例展示ICER估计及推断。
- 本文为最早呈现SMART成本效果分析结果的研究之一。
核心结论
- 本文提出了SMART设计中嵌入式动态治疗方案ICER的估计与推断方法,并以ADAPT-R试验为例给出结果。
研究设计与样本
- 方法学论文,提出基于影响曲线推断的靶向最大似然估计,并通过模拟评估性能。
- 以ADAPT-R试验(NCT02338739)的嵌入式方案为实例进行成本效果分析。
主要发现
- 模拟展示了所提估计与推断方法的性能。
- 以ADAPT-R试验为例给出旨在提高HIV护理依从性的嵌入式方案的ICER估计及推断。
临床怎么用
- 在SMART设计下可用所提靶向最大似然估计对嵌入式方案的ICER进行估计与推断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sequential multiple assignment randomized trials (SMARTs) have grown in popularity in recent years, and many of their study protocols propose conducting a cost-effectiveness analysis of the adaptive strategies embedded within them. The cost-effectiveness of these regimes is often proposed to be assessed using incremental cost-effectiveness ratios (ICERs). In this paper, we present an estimation and inference procedure for such cost-effectiveness measures for the embedded dynamic treatment regimes within a SMART design. In particular, we describe a targeted maximum likelihood estimator for the ICER of a SMART's embedded regimes with influence curve-based inference. We illustrate the performance of these methods using simulations. Throughout, we use as illustration a cost-effectiveness analysis for the Adaptive Strategies for Preventing and Treating Lapses of Retention in HIV Care (ADAPT-R; NCT02338739) trial, presenting estimated ICERs (with inference) for embedded regimes aimed at increasing HIV care adherence. This manuscript is one of the first to present cost-effectiveness analysis results from a SMART.
引用
- Montoya LM, Geng EH, Adhiambo HF, et al. Cost-Effectiveness Analyses for Sequential Multiple Assignment Randomized Trials. Stat Med. 2026. PMID: 42267580. doi:10.1002/sim.70634
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。